Biomarin Pharma
NAGLAZYME
Manufacturer:
Biomarin Pharma
Name:
NAGLAZYME
HCPCS Code Descriptor:
Injection, galsulfase, 1 mg
Category:
J Code
HCPCS:
J1458
NDC(s):
68135-0020-01
Primary Type:
Enzyme Replacement Therapy
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
NAGLAZYME is an Enzyme Replacement Therapy drug manufactured by Biomarin Pharma and administered via the Intravenous route of administration. The J Code: J1458 is aligned to the drug NAGLAZYME.